SYRA

SYRA

USD

Syra Health Corp. Class A Common Stock

$0.090-0.005 (-5.258%)

Preço em tempo real

Healthcare
Medical Care Facilities
Estados Unidos

Gráfico de preços

Loading Chart...

Métricas-chave

Métricas de mercado
Fundamentos da empresa
Estatísticas de negociação

Métricas de mercado

Abertura

$0.095

Máximo

$0.095

Mínimo

$0.090

Volume

0.00M

Fundamentos da empresa

Capitalização de mercado

1.1M

Setor

Medical Care Facilities

País

United States

Estatísticas de negociação

Volume médio

1.01M

Bolsa de valores

NCM

Moeda

USD

Faixa de 52 semanas

Mínimo $0.031Atual $0.090Máximo $2.27

Relatório de análise de IA

Última atualização: 5/05/2025
Gerado por IAFonte de dados: Yahoo Finance, Bloomberg, SEC

SYRA: Syra Health Corp. Class A Common Stock - What's Happening and What to Watch

Stock Symbol: SYRA Generate Date: 2025-05-05 00:20:25

Let's break down what's been going on with Syra Health's stock based on the latest information. We'll look at the news, how the price has moved, and what some automated predictions are saying.

The Latest Buzz: News Check

What's been hitting the news wires lately? Well, it's a bit of a mixed bag for Syra Health, but one piece of news is a really big deal.

Back in March, the company announced they snagged a nice contract extension worth $660,000 for their population health work. That sounds good, right? More business coming in is usually a positive sign for a company.

But then, just recently, on April 1st, came the other news: Syra Health is voluntarily delisting from the Nasdaq Capital Market. This is a significant move. When a company leaves a major exchange like Nasdaq, it often means they couldn't meet the listing requirements anymore, or they've decided to go private or trade on a less regulated market. For investors trading on Nasdaq, this is generally seen as a negative event. It can make the stock harder to buy and sell (less liquidity) and might signal underlying issues.

So, while getting a new contract is positive, the news about leaving Nasdaq is a much larger, and typically negative, development for a publicly traded stock.

Checking the Price Chart

Looking at the stock price itself over the last few months, things haven't been pretty. The price has been on a clear downward slide. Back in early February, shares were trading around $0.40 to $0.45. By the end of March, they had drifted down into the $0.20s.

Then came April 1st, the same day as the delisting announcement. The price took a sharp dive, falling significantly in the days that followed. It's been bouncing around at very low levels since then, often below $0.10. The recent price is a fraction of where it was just a couple of months ago.

An AI model is predicting small percentage increases for the next few days (around 1.9% to 2.8%). This suggests the model sees a potential tiny bounce from these extremely low levels in the very short term. However, the overall trend shown by the actual price history is strongly down, especially following that key news date.

Putting It All Together: What Might This Mean?

So, what's the picture when we combine the news and the price action?

The voluntary delisting from Nasdaq is the dominant factor here. The market's reaction, with the sharp price drop right after the announcement, confirms this is viewed negatively by investors trading on that exchange. While the contract extension is positive business news, it hasn't been enough to counter the impact of leaving Nasdaq.

Given the strong downtrend and the major negative news event (delisting), the situation for SYRA stock, particularly for those trading on Nasdaq, looks challenging. The AI's prediction of small short-term gains is interesting, but it's a tiny predicted move compared to the massive drop that has already occurred. The AI also mentions a much higher potential target price ($0.90), but this seems disconnected from the current reality of the price collapse and delisting.

The apparent near-term leaning, based on the news and price trend, is one of extreme caution. For investors focused on trading on major exchanges, the delisting event itself is often a signal to exit or avoid the stock due to reduced liquidity and visibility.

Potential Considerations (Use Extreme Caution):

  • For those already holding: The delisting significantly changes the investment landscape. If you're holding shares, you'll need to understand where they will trade next (likely over-the-counter) and the implications for liquidity. Setting a point where you'd get out if the price keeps falling – often called a stop-loss – makes sense to limit potential further losses, perhaps below the recent absolute lows (like $0.03 or $0.05), though volatility is very high at these levels.
  • For those considering buying: The delisting introduces significant risk and uncertainty. While the price is very low, and the AI sees potential for small short-term gains or a much larger move (though the latter seems questionable given the context), this is a highly speculative situation. The primary factor to consider is the impact of the delisting on future trading. Any potential entry would be highly risky and only for those comfortable with the implications of trading a delisted stock. The AI suggests potential entry points around $0.10 or $0.15, but the price has struggled to stay above these levels recently.

A Bit About the Company

Just to remember who we're talking about, Syra Health is a healthcare technology company. They work in areas like mental health, population health, and providing healthcare staff. The contract extension news fits right into their population health business. Keep in mind, this is a relatively small company (check the market cap) and the stock has shown extreme volatility, especially lately.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock trading involves significant risk, and you could lose money. Always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions. The delisting of a stock has significant implications that should be fully understood before trading.

Notícias relacionadas

PR Newswire

Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market

Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company dedicated to powering better health through...

Ver mais
Syra Health Announces Voluntary Delisting from the Nasdaq Capital Market
PR Newswire

Syra Health Secures $660,000 Population Health Contract Extension

Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company dedicated to powering better health through innovative technology products and...

Ver mais
Syra Health Secures $660,000 Population Health Contract Extension

Previsão de IABeta

Recomendação de IA

Altista

Atualizado em: 4/05/2025, 19:42

BaixistaNeutroAltista

72.0% Confiança

Risco e negociação

Nível de risco4/5
Alto risco
Adequado para
Valor
Guia de negociação

Ponto de entrada

$0.10

Tomar lucro

$0.16

Parar perda

$0.08

Fatores-chave

O preço atual está 4.0% acima da MA(20) em $0.09
DMI mostra tendência de baixa (ADX:24.0, +DI:47.6, -DI:48.4), sugerindo cautela
O preço atual está extremamente próximo do nível de suporte ($0.09), sugerindo forte oportunidade de compra
MACD 0.0078 está acima da linha de sinal 0.0036, indicando um crossover de alta

Mantenha-se atualizado

Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.